Net Cash Provided by (Used in) Operating Activities |
2.3M |
USD |
+136% |
Q2 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
-24K |
USD |
-1100% |
Q2 2023 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
-40K |
USD |
+88.1% |
Q2 2024 |
Q1 2025 |
Common Stock, Shares Authorized |
10M |
shares |
0% |
Q2 2024 |
Q1 2025 |
Common Stock, Shares, Issued |
8.5M |
shares |
0% |
Q2 2024 |
Q1 2025 |
Common Stock, Par or Stated Value Per Share |
0.1 |
USD/shares |
0% |
Q2 2024 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
2.26M |
USD |
+269% |
Q2 2024 |
Q1 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
1K |
USD |
|
Q2 2024 |
Q1 2025 |
Payments to Acquire Property, Plant, and Equipment |
105K |
USD |
-47.8% |
Q2 2024 |
Q1 2025 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
8.11M |
USD |
+34.9% |
Q2 2024 |
Q1 2025 |
Property, Plant and Equipment, Gross |
7.35M |
USD |
+3.35% |
Q1 2024 |
FY 2024 |
Deferred Income Tax Expense (Benefit) |
613K |
USD |
+193% |
Q2 2024 |
Q1 2025 |
Current Income Tax Expense (Benefit) |
2.51M |
USD |
+124% |
Q2 2024 |
Q1 2025 |
Preferred Stock, Shares Authorized |
1M |
shares |
0% |
Q2 2024 |
Q1 2025 |
Additional Paid in Capital |
1.93M |
USD |
0% |
Q2 2024 |
Q1 2025 |
Depreciation, Depletion and Amortization |
495K |
USD |
+8.79% |
Q2 2024 |
Q1 2025 |